Literature DB >> 10022852

A premature termination codon interferes with the nuclear function of an exon splicing enhancer in an open reading frame-dependent manner.

A Gersappe1, D J Pintel.   

Abstract

Premature translation termination codon (PTC)-mediated effects on nuclear RNA processing have been shown to be associated with a number of human genetic diseases; however, how these PTCs mediate such effects in the nucleus is unclear. A PTC at nucleotide (nt) 2018 that lies adjacent to the 5' element of a bipartite exon splicing enhancer within the NS2-specific exon of minute virus of mice P4 promoter-generated pre-mRNA caused a decrease in the accumulated levels of P4-generated R2 mRNA relative to P4-generated R1 mRNA, although the total accumulated levels of P4 product remained the same. This effect was seen in nuclear RNA and was independent of RNA stability. The 5' and 3' elements of the bipartite NS2-specific exon enhancer are redundant in function, and when the 2018 PTC was combined with a deletion of the 3' enhancer element, the exon was skipped in the majority of the viral P4-generated product. Such exon skipping in response to a PTC, but not a missense mutation at nt 2018, could be suppressed by frame shift mutations in either exon of NS2 which reopened the NS2 open reading frame, as well as by improvement of the upstream intron 3' splice site. These results suggest that a PTC can interfere with the function of an exon splicing enhancer in an open reading frame-dependent manner and that the PTC is recognized in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022852      PMCID: PMC83958          DOI: 10.1128/MCB.19.3.1640

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

Review 1.  RNA-RNA interactions in the spliceosome: unraveling the ties that bind.

Authors:  T W Nilsen
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

2.  Proofreading and aminoacylation of tRNAs before export from the nucleus.

Authors:  E Lund; J E Dahlberg
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

3.  G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection.

Authors:  A J McCullough; S M Berget
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

Review 4.  Nonsense-mediated mRNA decay in yeast.

Authors:  S W Peltz; F He; E Welch; A Jacobson
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1994

5.  An evolutionarily conserved U5 snRNP-specific protein is a GTP-binding factor closely related to the ribosomal translocase EF-2.

Authors:  P Fabrizio; B Laggerbauer; J Lauber; W S Lane; R Lührmann
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

6.  Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.

Authors:  N Shiga; Y Takeshima; H Sakamoto; K Inoue; Y Yokota; M Yokoyama; M Matsuo
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  Intron definition is required for excision of the minute virus of mice small intron and definition of the upstream exon.

Authors:  D D Haut; D J Pintel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  CA- and purine-rich elements form a novel bipartite exon enhancer which governs inclusion of the minute virus of mice NS2-specific exon in both singly and doubly spliced mRNAs.

Authors:  A Gersappe; D J Pintel
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  Frameshift mutations in the v-src gene of avian sarcoma virus act in cis to specifically reduce v-src mRNA levels.

Authors:  S B Simpson; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping.

Authors:  P Belgrader; L E Maquat
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

View more
  8 in total

1.  Effect of intercistronic length on internal ribosome entry site (IRES) efficiency in bicistronic mRNA.

Authors:  J Attal; M C Theron; C Puissant; L M Houdebine
Journal:  Gene Expr       Date:  1999

2.  Stop codon-mediated suppression of splicing is a novel nuclear scanning mechanism not affected by elements of protein synthesis and NMD.

Authors:  Chaim Wachtel; Binghui Li; Joseph Sperling; Ruth Sperling
Journal:  RNA       Date:  2004-09-23       Impact factor: 4.942

3.  Alternative splicing induced by nonsense mutations in the immunoglobulin mu VDJ exon is independent of truncation of the open reading frame.

Authors:  Marc Bühler; Oliver Mühlemann
Journal:  RNA       Date:  2004-12-21       Impact factor: 4.942

4.  Nonsense-mediated decay of glutathione peroxidase 1 mRNA in the cytoplasm depends on intron position.

Authors:  X Sun; P M Moriarty; L E Maquat
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  Premature termination codons do not affect the rate of splicing of neighboring introns.

Authors:  J Robin Lytle; Joan A Steitz
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

6.  A premature termination codon mutation at the C terminus of foamy virus Gag downregulates the levels of spliced pol mRNA.

Authors:  Eun-Gyung Lee; Daniel Kuppers; Megan Horn; Jacqueline Roy; Cynthia May; Maxine L Linial
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

Review 7.  Control of gene expression through the nonsense-mediated RNA decay pathway.

Authors:  Andrew Nickless; Julie M Bailis; Zhongsheng You
Journal:  Cell Biosci       Date:  2017-05-19       Impact factor: 7.133

8.  Frame-disrupting mutations elicit pre-mRNA accumulation independently of frame disruption.

Authors:  J Saadi Imam; Jayanthi P Gudikote; Wai-Kin Chan; Miles F Wilkinson
Journal:  Nucleic Acids Res       Date:  2009-12-09       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.